Your browser doesn't support javascript.
loading
Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26 years in the United States.
Chesson, Harrell W; Meites, Elissa; Ekwueme, Donatus U; Saraiya, Mona; Markowitz, Lauri E.
Afiliação
  • Chesson HW; Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: HChesson@cdc.gov.
  • Meites E; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Ekwueme DU; Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Saraiya M; Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Markowitz LE; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Vaccine ; 36(29): 4362-4368, 2018 07 05.
Article em En | MEDLINE | ID: mdl-29887325

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Análise Custo-Benefício / Infecções por Papillomavirus / Vacinas contra Papillomavirus Tipo de estudo: Health_economic_evaluation Limite: Adolescent / Adult / Child / Female / Humans / Male País como assunto: America do norte Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Análise Custo-Benefício / Infecções por Papillomavirus / Vacinas contra Papillomavirus Tipo de estudo: Health_economic_evaluation Limite: Adolescent / Adult / Child / Female / Humans / Male País como assunto: America do norte Idioma: En Ano de publicação: 2018 Tipo de documento: Article